Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 70518-4345

3 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 70518-4345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylprednisolone Sodium Succinate For Injection 1)

Chemical Structure (Methylprednisolone Sodium Succinate For Injection 1)
Chemical structure of Methylprednisolone Sodium Succinate shown as a molecular diagram depicting its atoms and bonds in a steroid framework with succinate and sodium groups.*
FDA Label Image

Mm1 (Methylprednisolone Sodium Succinate 125mg Per Vial 70518 4345 00)

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Methylprednisolone Sodium Succinate Injection 125 mg per vial, powder for solution. The label indicates quantity as 25 vials of 2 mL each. It is labeled for intramuscular or intravenous use, single-dose vials, with storage instructions and warnings. The product is repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Hikma, Berkeley Heights, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.